Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Chipotle turns to Taco Bell's 'Doritos Locos' chief as new CEO
-
Soleno Therapeutics Inc. (SLNO) PT Lowered to $4 at Maxim Group; 'Distressed Valuation Without Data Makes Raising Capital Difficult'
-
UPDATE: Maxim Group Downgrades MYnd Analytics (MYND) to Hold Amid Cash Burh
-
Athersys (ATHX) PT Lowered to $6 at Maxim Group; Few Catalysts in the Year Ahead
-
UPDATE: Maxim Group Downgrades ContraVir Pharma (CTRV) at Hold
-
Cytori Therapeutics, Inc. (CYTX) PT Lowered to $4 at Maxim Group Ahead of Binary Event
-
Helios and Matheson (HMNY) Prices Stock Offering at $5.50 w/Warrants
-
Helios and Matheson Analytics Announces Pricing of $105 Million Public Offering
-
Helios and Matheson (HMNY) Plans Public Offering of Common Stock, Warrants
-
Helios and Matheson Analytics Announces Proposed Public Offering of Common Stock and Warrants
-
Viveve Announces Closing of Public Offering of Shares of Common Stock
-
Maxim Group Downgrades Determine (DTRM) to Sell
-
Actinium Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record
-
Actinium Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record
-
Maxim Group Upgrades Control4 Corporation (CTRL) to Buy
-
Virtusa (VRTU) PT Raised to $59 at Maxim Group
-
Viveve Medical (VIVE) Prices 10M Share Common Offering at $3/Sh
-
Viveve Announces Pricing of Public Offering of Shares of Common Stock
-
Xplore Technologies (XPLR) PT Raised to $6 at Maxim Group
-
Actinium Pharmaceuticals Reminds Investors of Record Date for Rights Offering
-
Actinium Pharmaceuticals Reminds Investors of Record Date for Rights Offering
-
Chipotle Mexican Grill (CMG) PT Lowered to $410 at Maxim Group
-
Viking Therapeutics Announces Closing of Public Offering of Common Stock
-
Wall Street says Starbucks has too many stores, prices too high
-
Viking Therapeutics (VKTX) Prices 11M Shares at $5
-
Viking Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock
-
Sensus Healthcare (SRTS) PT Raised to $9 at Maxim Group
-
Maxim Group Upgrades Tableau Software (DATA) to Hold
-
Actinium Pharma (ATNM) Announces Rights Offering
-
Actinium Pharmaceuticals Announces Rights Offering
-
Actinium Pharmaceuticals Announces Rights Offering
-
Maxim Group Downgrades Cellular Biomedicine Group (CBMG) to Hold
-
Maxim Group Starts Celsius Holdings (CELH) at Buy
-
BeiGene, Ltd. (BGNE) PT Raised to $144 at Maxim Group
-
First Savings Financial Group (FSFG) PT Raised to $70 at Maxim Group
-
Vuzix Corp. (VUZI) PT Raised to $13 at Maxim Group
-
Coffee Holding Co. (JVA) PT Raised to $8 at Maxim Group
-
Vuzix Announces Closing of Above Market $30,000,000 Offering
-
MoviePass (HMNY) 'Flexes Its Muscle' by Excluding Some Theaters - Maxim Group
-
Pre-Open Stock Movers 01/26: (EGHT) (ABBV) (INTC) Higher; (SBUX) (BBBY) (ETFC) Lower (more...)
-
Maxim Group Starts Atossa Genetics (ATOS) at Buy
-
Brinker Int'l (EAT) PT Raised to $52 at Maxim Group
-
Vuzix Corp. (VUZI) to Sell 3M Shares at $10 with Warrants
-
Vuzix Announces $30,000,000 Above Market Intra-Day Registered Direct Offering
-
Recon Technology, Ltd. Announces Closing of Approximately $6.0 Million Ordinary Share Registered Direct Offering
-
Sterling Bancorp (STL) PT Raised to $32 at Maxim Group
-
Aspen REIT’s Initial Public Offering is Qualified by SEC
-
Workhorse Group (WKHS) PT Raised to $6 at Maxim Group
-
Maxim Group Downgrades Juno Therapeutics (JUNO) to Hold Following Acquisition
-
Recon Technology (RCON) Prices $6M Ordinary Share Registered Direct Offering

